Further analyses of B-ALL subtypes revealed varying but consistently elevated levels of LGALS9 expression in samples from patients with different subtypes of B-ALL relative to levels found in normal PBMCs (Fig. 5g). The gene discussed is LGALS9; the disease is precursor B-cell acute lymphoblastic leukemia.